BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2761916)

  • 1. CA 125, NB/70K, and lipid-associated sialic acid in monitoring uterine papillary serous carcinoma.
    Tseng PC; Sprance HE; Carcangiu ML; Chambers JT; Schwartz PE
    Obstet Gynecol; 1989 Sep; 74(3 Pt 1):384-7. PubMed ID: 2761916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma lipid-associated sialic acid and serum CA 125 as indicators of disease status with advanced ovarian cancer.
    Vardi JR; Tadros GH; Foemmel R; Shebes M
    Obstet Gynecol; 1989 Sep; 74(3 Pt 1):379-83. PubMed ID: 2761915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid associated sialic acid in plasma in patients with advanced carcinoma of the ovaries.
    Vardi JR; Tadros GH; Malhotra C; Charney T; Shebes M; Foemmel R
    Surg Gynecol Obstet; 1989 Apr; 168(4):296-301. PubMed ID: 2928903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor markers CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen in patients with adenocarcinoma of the uterine cervix.
    Duk JM; Aalders JG; Fleuren GJ; Krans M; De Bruijn HW
    Obstet Gynecol; 1989 Apr; 73(4):661-8. PubMed ID: 2648225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of three tumor markers--CA-125, lipid-associated sialic acid (LSA), and NB/70K--in monitoring ovarian cancer.
    Petru E; Sevin BU; Averette HE; Koechli OR; Perras JP; Hilsenbeck S
    Gynecol Oncol; 1990 Aug; 38(2):181-6. PubMed ID: 2387533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preoperative levels of CA 125 and risk factors in adenocarcinoma of the endometrium].
    Marcello C; Corda F; Pilloni MD; Puligheddu P; Lecca U
    Ann Ostet Ginecol Med Perinat; 1989; 110(6):290-5. PubMed ID: 2639616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of mucin-like carcinoma-associated antigen (MCA), CA 125, CA 19-9 and CEA in patients with ovarian cancer.
    Koelbl H; Schieder K; Neunteufel W; Bieglmayer C
    Neoplasma; 1989; 36(4):473-8. PubMed ID: 2770933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring endometrial adenocarcinoma with a four tumor marker combination. CA 125, squamous cell carcinoma antigen, CA 19.9 and CA 15.3.
    Matorras R; Rodríguez-Escuderoi FJ; Diez J; Genollá J; Cruz Fombellida J; Ruibal A
    Acta Obstet Gynecol Scand; 1992 Aug; 71(6):458-64. PubMed ID: 1326844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tumor markers in the monitoring of ovarian cancer].
    Xu SX
    Zhonghua Fu Chan Ke Za Zhi; 1990 Nov; 25(6):345-7, 383. PubMed ID: 2282861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Ca 125 as tumor marker in ovarian carcinoma.
    Krebs HB; Goplerud DR; Kilpatrick SJ; Myers MB; Hunt A
    Obstet Gynecol; 1986 Apr; 67(4):473-7. PubMed ID: 3008052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [N-acetylneuraminic acid (sialic acid) as a tumor marker in head and neck cancers].
    Fischer F; Egg G
    HNO; 1990 Oct; 38(10):361-3. PubMed ID: 2283329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of neopterin determination as a tumour marker in ovarian cancer.
    Szarka G; Pulay T; Csömör S; Tran-Phoung-Mai ; Schumann B
    Acta Chir Hung; 1988; 29(4):359-64. PubMed ID: 3239335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Usefulness of sialic acid as a tumor marker].
    Feliú J; Daimiel E; Vicente J; Martín G; García Girón C; Chacón I; González Barón M
    Rev Clin Esp; 1989 May; 184(8):401-3. PubMed ID: 2781072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serum lipid-bound sialic acid as a marker in lung cancer patients].
    Iwahashi N
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Dec; 28(12):1599-607. PubMed ID: 2077205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of serum CA125 and lipid-associated sialic acid tumor-associated antigen levels to the disease status of patients with gynecologic malignancies.
    Stratton JA; Rettenmaier MA; Phillips HB; Herabutya S; DiSaia PJ
    Obstet Gynecol; 1988 Jan; 71(1):20-6. PubMed ID: 2827081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The value of tumor markers in colorectal cancer].
    Peters KM; Grundmann R
    Leber Magen Darm; 1989 Jan; 19(1):18-25. PubMed ID: 2927234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of polyamine determination in monitoring malignant gynaecological tumours.
    Szarka G; Pulay T; Csömör S; Tran-Phuong-Mai ; Schumann B
    Acta Chir Hung; 1988; 29(4):365-72. PubMed ID: 3239336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sialic acid and carcinoembryonic antigen (CEA) as markers of colon cancer: Preliminary report].
    Dabrowska B; Krasnodebski IW; Tadeusiak W
    Pol Tyg Lek; 1991 Nov 11-25; 46(45-47):890-1. PubMed ID: 1669462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of serum sialic acid, heat stable alkaline phosphatase and fucose as markers of breast carcinoma.
    Patel PS; Baxi BR; Adhvaryu SG; Balar DB
    Anticancer Res; 1990; 10(4):1071-4. PubMed ID: 2382978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum CA 125 levels in patients with endometriosis: changes in CA 125 levels during menstruation.
    Masahashi T; Matsuzawa K; Ohsawa M; Narita O; Asai T; Ishihara M
    Obstet Gynecol; 1988 Sep; 72(3 Pt 1):328-31. PubMed ID: 3165507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.